Warby Parker Inc. WRBY
We take great care to ensure that the data presented and summarized in this overview for Warby Parker Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WRBY
View all-
Vanguard Group Inc Valley Forge, PA9.82MShares$187 Million0.0% of portfolio
-
Durable Capital Partners LP Bethesda, MD9.02MShares$171 Million1.89% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$138 Million0.0% of portfolio
-
General Catalyst Group Management, LLC5.66MShares$107 Million12.77% of portfolio
-
D1 Capital Partners L.P. New York, NY5.26MShares$100 Million2.8% of portfolio
-
Vaughan Nelson Investment Management, L.P.2.65MShares$50.3 Million0.6% of portfolio
-
Marshall Wace, LLP London, X02.24MShares$42.5 Million0.07% of portfolio
-
Baillie Gifford & CO2.15MShares$40.8 Million0.04% of portfolio
-
State Street Corp Boston, MA2.15MShares$40.8 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$40.7 Million0.03% of portfolio
Latest Institutional Activity in WRBY
Top Purchases
Top Sells
About WRBY
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Insider Transactions at WRBY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2025
|
Joel E Cutler |
SELL
Other acquisition or disposition
|
Indirect |
5,656,571
-100.0%
|
-
|
Mar 04
2025
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,684
-5.4%
|
$268,732
$23.52 P/Share
|
Mar 04
2025
|
Steven Clive Miller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,731
+11.36%
|
-
|
Mar 04
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,967
-53.86%
|
$643,241
$23.52 P/Share
|
Mar 04
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,271
+5.93%
|
-
|
Mar 04
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
26,088
+34.9%
|
-
|
Mar 04
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
202,968
-57.62%
|
$4,668,264
$23.65 P/Share
|
Mar 04
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
201,088
+40.78%
|
-
|
Mar 04
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,271
+5.91%
|
-
|
Mar 03
2025
|
Steven Clive Miller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,321
-3.24%
|
$151,704
$24.16 P/Share
|
Mar 03
2025
|
Steven Clive Miller Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,128
+7.2%
|
-
|
Mar 03
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
150,000
-52.31%
|
$3,600,000
$24.72 P/Share
|
Mar 03
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
150,000
+46.5%
|
-
|
Mar 03
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,858
-36.29%
|
$308,592
$24.17 P/Share
|
Mar 03
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,250
+39.62%
|
-
|
Mar 03
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,858
-36.16%
|
$308,592
$24.17 P/Share
|
Mar 03
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,250
+39.54%
|
-
|
Jan 30
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-80.42%
|
$1,350,000
$27.61 P/Share
|
Jan 30
2025
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+44.57%
|
-
|
Jan 03
2025
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,996
-75.04%
|
$924,900
$25.41 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 177K shares |
---|---|
Conversion of derivative security | 2.34M shares |
Exercise of conversion of derivative security | 283K shares |
Open market or private purchase | 75K shares |
Open market or private sale | 8.1M shares |
---|---|
Payment of exercise price or tax liability | 32K shares |
Other acquisition or disposition | 5.66M shares |